WO2006071243A1 - Medical devices including metallic films and methods for making same - Google Patents

Medical devices including metallic films and methods for making same Download PDF

Info

Publication number
WO2006071243A1
WO2006071243A1 PCT/US2005/006993 US2005006993W WO2006071243A1 WO 2006071243 A1 WO2006071243 A1 WO 2006071243A1 US 2005006993 W US2005006993 W US 2005006993W WO 2006071243 A1 WO2006071243 A1 WO 2006071243A1
Authority
WO
Grant status
Application
Patent type
Prior art keywords
endoprosthesis
tubular
tubular framework
framework
metallic film
Prior art date
Application number
PCT/US2005/006993
Other languages
French (fr)
Inventor
Masoud Molaei
John Peckham
Original Assignee
Boston Scientific Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/92Stents in the form of a rolled-up sheet expanding after insertion into the vessel, e.g. with a spiral shape in cross-section
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2002/9522Means for mounting a stent onto the placement instrument
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped

Abstract

An endoprosthesis (150) for deployment within a body passage includes an external tubular framework (152) disposed about a tubular member (154), e.g., a metallic film having a thickness of about 50 µm or less. The tubular member may be sandwiched between the external tubular framework and an internal tubular framework located internally of the external tubular framework and the tubular member. Whether or not the internal tubular framework is included, the endoprosthesis can be self-expanding. During deployment of the endoprosthesis using a deployment device (30), the external tubular framework prevents substantial frictional contact between the deployment device and the tubular member.

Description

MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME

FIELD OF THE INVENTION The invention relates to medical devices, such as endoprostheses, and methods of making the devices.

BACKGROUND

The body includes various passageways such as arteries, other blood vessels, and other body lumens. These passageways sometimes become occluded or weakened. For example, the passageways can be occluded by a tumor, restricted by plaque, or weakened by an aneurysm. When this occurs, the passageway can be reopened or reinforced, or even replaced, with a medical endoprosthesis. An endoprosthesis is typically a tubular member that is placed in a lumen in the body. Endoprostheses can be delivered inside the body by a catheter that supports the endoprosthesis in a compacted or reduced-size form as the endoprosthesis is transported to a desired site. Upon reaching the site, the endoprosthesis is expanded, for example, so that it can contact the walls of the lumen. The expansion mechanism may include forcing the endoprosthesis to expand radially. For example, the expansion mechanism can include the catheter carrying a balloon, which carries a balloon-expandable endoprosthesis. The balloon can be inflated to deform and to fix the expanded endoprosthesis at a predetermined position in contact with the lumen wall. The balloon can then be deflated, and the catheter withdrawn.

In another delivery technique, the endoprosthesis is formed of an elastic material that can be reversibly compacted and expanded, e.g., elastically or through a material phase transition. During introduction into the body, the endoprosthesis is restrained in a radially compacted condition. Upon reaching the desired implantation site, the restraint is removed, for example, by retracting a restraining device such as an outer sheath, enabling the endoprosthesis to self-expand by its own internal elastic restoring force. SUMMARY OF THE INVENTION

The invention relates to medical devices, such as endoprostheses, and methods of making the devices. Exemplary endoprostheses include stents, covered stents, and stent- grafts. hi some embodiments, an endoprosthesis for deployment within a body passage includes a tubular framework and a metallic film having a thickness of about 50 μm or less and disposed internally of the tubular framework. The endoprosthesis may be self- expanding.

The tubular framework may have an internal surface. The metallic film, which may be generally tubular in shape, may have an outer surface that contacts the internal surface of the tubular framework.

The film may be a deposited metallic film including, e.g., deposited nickel and titanium. The deposited film may have a thickness of about 50 μm or less, 50 μm or less, e.g., about 35 μm or less. The deposited film may have a thickness of 4 μm or greater. The film may exhibit super-elastic properties. In embodiments, the film is not shape set.

The endoprosthesis, when in a deployed state within a body passage, may exert an outward radial force against the body passage, with essentially all of the outward radial force resulting from the tubular framework. The endoprosthesis may have an internal surface that is substantially defined by an internal surface of the metallic film.

In embodiments, the endoprosthesis includes only one framework. hi some embodiments, the endoprosthesis includes at least a second tubular framework. At least a portion or all of the metallic film is sandwiched between the tubular framework and the second tubular framework. The endoprosthesis may be self expanding. In embodiments, neither the tubular framework nor the second tubular framework, by itself, exerts a radial force sufficient to secure the endoprosthesis within a body passage but together, the tubular framework and second tubular framework exert force sufficient to secure the endoprosthesis. In a deployed state, the tubular framework and the second tubular framework may each exert a radial force. The radial force of the second tubular framework may greater than the radial force of the tubular framework.

A total radial thickness of the tubular framework and the second tubular framework may be about 75 microns or less. The tubular framework and the second tubular framework may have at least some relative freedom of movement along at least one of the radial, circumferential, and longitudinal dimensions..

Substantially all or all of the metallic film may be a single layer. In some embodiments, a self-expanding endoprosthesis for deployment within a body passage includes a first tubular framework, a tubular member disposed around the first tubular framework, and a second tubular framework disposed around the tubular member.

In embodiments, neither of the first and second tubular frameworks alone exerts sufficient outward radial force to self-expand the endoprosthesis within a body passage but the first and second tubular frameworks together exert sufficient outward radial force to self-expand the endoprosthesis. The film may be a deposited metallic film including, e.g., deposited nickel and titanium. The deposited film may have a thickness of about 50 μm or less, 50 μm or less, e.g., about 35 μm or less. The deposited film may have a thickness of 4 μm or greater. The film may exhibit super-elastic properties. In embodiments, the film is not shape set. In embodiments, a delivery device for deploying an endoprosthesis within a body passage includes an elongate inner member, a self-expanding endoprosthesis disposed about a distal portion of the inner member, the endoprosthesis comprising a tubular framework disposed about a deposited metallic film and an outer sheath surrounding the elongate inner member and the self-expanding endoprosthesis, wherein the tubular framework prevents substantial factional contact between the tubular member and the outer sheath.

In one aspect, the invention features an endoprosthesis including a metallic film, e.g., a vapor deposited film, including nickel, titanium, and chromium. A ratio of a weight of chromium of the metallic film to a combined weight of nickel, titanium, and chromium of the metallic film is at least 0.001 and can be less than 0.0075. Other aspects, features, and advantages of the invention will be apparent from the description of the preferred embodiments thereof and from the claims.

BRIEF DESCRIPTION OF THE FIGURES Fig. 1 is a side view of an endoprosthesis in the radially expanded state as deployed within a body passage adjacent an aneurysm.

Fig. 2a is a side view of a distal portion of a deployment device prior to radial expansion of the endoprosthesis.

Fig. 2b is a side view of the distal portion of the deployment device subsequent to radial expansion of the endoprosthesis adjacent the aneurysm.

Fig. 3 is a perspective view of an endoprosthesis.

Fig. 4 is a perspective view of an endoprosthesis.

Fig. 5 is an end-on cross-sectional view of an endoprosthesis.

DETAILED DESCRIPTION

Referring to Fig. 1, an endoprosthesis 100 is deployed within a body passage, e.g., within a vessel weakened by an aneurysm, e.g., an aneurysm 25 of a vessel 26 of a human brain. Endoprosthesis 100 includes a framework, e.g., a stent body 52, covered by a tubular member or cover 54, made of thin metallic film. The stent body provides a relatively rigid framework that secures the endoprosthesis at the treatment site. The framework defines relatively large openings or fenestrations that contribute to the mechanical properties of the stent. The cover 54 is relatively thin and flexible and includes smaller fenestrations that contribute to the mechanical properties of the cover and can occlude the fenestrations of the stent. In some embodiments, endoprosthesis 100 modifies an amount or velocity of blood passing between vessel 26 and aneurysm 25. For example, prosthesis 100 can be deployed to reduce or block blood flow between vessel 26 and aneurysm 25, e.g., to occlude the aneurysm 25. If so deployed, prosthesis 100 may sufficiently reduce blood flow to allow clotting or other healing processes to take place within aneurysm 25 and/or opening 29 thereof. Tubular member 54 can provide a greater attenuation of the blood flow into the aneurysm 25 than stent body 52 alone. Endoprosthesis 100, however, can allow some flow to pass between vessel 26 and aneurysm 25 even while providing some reduction in the rate and/or volume of flow. Prosthesis 100 can also (or alternatively) allow blood to pass between vessel 26 containing the prosthesis and adjacent vessels, e.g., feeder vessel 27, while still providing reduced flow with respect to the aneurysm.

Referring to Fig. 2a, endoprosthesis 100 is deployed to aneurysm 25 using a deployment device 30, which includes a retractable outer sheath 31 and an inner catheter 32. Fig. 2a shows only a distal portion of the delivery device. An operator manipulates the device 30 using a proximal portion (not shown). Device 30 is introduced over a guide wire 37 extending along an interior 28 of vessel 26. During introduction, the endoprosthesis 100 is radially compacted between outer sheath 31 and inner catheter 32 adjacent a distal end 40 of the outer sheath. Endoprosthesis 100 is longitudinally restrained by a proximal stop 33 and a distal tip 34 of inner catheter 32. Device 30 includes distal and proximal markers 38,39, which can be radiographically monitored to determine when endoprosthesis 100 has reached aneurysm 25. Prosthesis 100 includes markers 75, to provide radiopacity, which can also or alternatively be used to visualize the position of endoprosthesis 100.

With reference to Fig. 2b, the outer sheath 31 is retracted upon reaching the desired deployment site, e.g., aneurysm 25. In some embodiments, endoprosthesis 100 self-expands by its own internal elastic restoring force when the radially restraining outer sheath is retracted. Alternatively, or in combination with self-expansion, deployment of prosthesis 100 may include use of a balloon or other device to radially expand prosthesis 100 within vessel 26. The inner catheter 32 and guide wire 37 are withdrawn from vessel 26. Suitable delivery systems include the Neuroform, Neuroform2, and Wingspan Stent System available from Boston Scientific Target Therapeutics, Fremont, CA. In embodiments, the outer sheath and/or inner catheter includes a reinforcing member to respectively resist elongation or compression as the outer sheath is withdrawn. Such reinforcing members include polymer shafts, braids, and coil structures. Endoprosthesis 100 can be deployed using a guidewireless deployment device. Upon expansion, endoprosthesis 100 assumes a shape and radial extent generally coextensive with an inner surface of the vessel 26, e.g., a tubular shape centered about a longitudinal axis a! of the prosthesis (Fig. 1). Depending upon the application, prosthesis 100 can have a diameter d of between, for example, 1 mm to 46 mm. In certain embodiments, a prosthesis for deployment within a vessel at an aneurysm can have an expanded diameter d of from about 2 mm to about 6 mm, e.g., about 2.5 mm to about 4.5 mm. Depending upon the application, prosthesis 100 can have a length along axis a.\ of at least 5 mm, at least 10 mm, e.g., at least about 30 mm. An exemplary embodiment has an expanded diameter of about 3.5 mm and a length of about 15 mm. In embodiments, the stent body has a closed cell framework, an open cell framework, a helical framework, a braided framework, or combination thereof.

In some embodiments the tubular member 54 of endprosthesis 100 includes a metallic film deposited by a vapor deposition process. Vapor deposited materials are formed by depositing film constituents from a vapor or a vacuum onto a surface. In embodiments, the constituents are vaporized by bombarding, heating or sputtering a bulk target. The vaporized constituents deposit on a substrate to form the film. Deposited films can exhibit highly uniform thickness and microstructure in very thin films, e.g. about 50 microns or less, e.g. 4-35 microns. Suitable vapor deposition processes are described in Busch et al. U.S. 5,061,914, Bose et al. U.S. 6,605,111, Johnston U.S. 6,533,905, and Gupta et al. U.S. 2004/0014253, the entire contents of all of which are hereby incorporated by reference.

In some embodiments, the deposited film can include an alloy of nickel and titanium present in amounts sufficient to provide the deposited film with desirable mechanical or shape memory properties. For example, the film may include an alloy, e.g., a superelastic or pseudo-elastic metal alloy, as described, for example, in Schetsky, L. McDonald, "Shape Memory Alloys," Encyclopedia of Chemical Technology (3rd ed.), John Wiley & Sons, 1982, vol. 20. pp. 726-736; and commonly assigned U.S.S.N. 10/346,487, filed January 17, 2003. The alloy may be nitinol. The alloy may include a third compound, e.g., chromium, which modifies a mechanical property, e.g., a hardness or elasticity, of the film. Tubular member 54 may include a deposited metal film including nickel, titanium, and, optionally, chromium. Exemplary films and deposition of such films is described in U.S. application no. **/***5***5 filed concurrently herewith, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, attorney docket no. 10527-570001, which application is incorporated herein by reference. Referring to Fig. 3, an endoprosthesis 150 includes a framework, e.g., stent body

152, and a tubular member 154 disposed internally of stent body 152. Stent body 154 is defined by a plurality of circumferential bands 157 connected by longitudinal members 158 and defining fenestrations 160 therebetween. Tubular member 154 may be a deposited metallic film. Although not shown in Fig. 3, tubular member 154 may define a plurality of fenestrations, e.g., as discussed for tubular member 54. Because tubular member 154 is disposed internally of stent body 152, an interior 162 of endoprosthesis 150 is defined by a surface 163 of tubular member 154 and presents a generally smoother topography, e.g., with fewer projections, than if stent body 152 were internal of the tubular member. During introduction via a delivery device along a body passageway, e.g., within a blood vessel, stent body 152 is positioned between the surrounding delivery device, e.g., the outer sheath 31 of device 30, and the tubular member 154. Upon deployment, as the outer sheath is retracted over the endoprosthesis, the substantially all or all of any friction between the sheath and endoprosthesis is experienced by the stent body 152 not the tubular member 154. For example, at least about 75% or at least 90% of the frictional contact between the sheath and the endoprosthesis during radial expansion may be between an inner surface of the outer sheath and the tubular framework. Such a configuration can protect the tubular member from damage, e.g., tears, when the endoprosthesis is loaded into the delivery device and during deployment. As the endoprosthesis 150 radially expands against a body passageway, stent body 152 can limit or prevent contact between the internal surface of the body passageway and the tubular member. For example, locating the tubular member internal of the stent body prevents the stent body from forcing the tubular member against the body passageway during radial expansion. Hence, fenestrations of the tubular member, if present, will not slide with significant force against the body passageway internal surface so as to minimize mechanical damage from the fenestrations to the body passageway.

In embodiments, the endoprosthesis is a re-sheathable endoprosthesis, such as a closed cell stent body with internal tubular member.

Once deployed, tubular member 154 shields blood flowing longitudinally through the endoprosthesis from stent body 152, e.g., from circumferential bands 157 and longitudinal members 158. Hence, a tendency for the blood flow to be disrupted or perturbed by stent body 152 is reduced or eliminated. A tendency for blood to clot within the interior 162 is also reduced or eliminated because the generally smoother topography presented by tubular member 154 offers fewer projections than if stent body 152 were internal of tubular memb er 152.

Because stent body 152 is disposed of connected circumferential bands rather than a more contiguous surface, stent body 152 presents less surface area to the wall of the passageway than would tubular member 154. Consequently, when radially expanded against the wall of a body passageway, e.g., vessel 26, endoprosthesis 150 produces less metal to tissue contact than if the stent body 152 were not positioned between the passageway wall and the tubular member 154. Additionally, interstices created by stent body 152 between the passageway wall and tubular member 154 can enhance endothelial growth and recovery.

Endoprosthesis 150 can be assembled by overexpanding stent body 152 to a greater diameter than it assumes in a body passageway and then sliding or drawing the tubular member into the interior of the stent body. Subsequently, stent body 152 is allowed to contract against the tubular member. In embodiments, when expanded within a body passageway, the tubular member is about as long as the stent body and may be shorter. The tubular member and stent body can be secured, e.g., mechanically, with adhesive, or combination thereof. As shown, filaments 101 pass around portions of stent body 152 and through fenestrations 165 of tubular member 154. Filaments 101 can be formed of a polymer, a suture, a ductile metal wire, such as nitinol or gold wire, or other suitable material. In some embodiments, the tubular member differs from a fabric at least in that the tubular member is a metallic film that lacks fibers that can be pushed apart to receive a filament as by sewing a fabric. Accordingly, the fenestrations can be formed prior to the process of passing the filament through the tubular member. Fenestrations that receive the filaments can be formed by, e.g., etching, laser cutting, or a photolithographic process. Other mechanical securing structures include fasteners, such as grommets and rivets. Securing techniques are described in USSN , {Attorney

Docket No. 10527-566001}, filed contemporaneously herewith and incorporated herein by reference.

In embodiments, substantially all of the radial outward force exerted by endoprosthesis 150 is due to stent body 152. In some embodiments, tubular member 154 is a deposited metallic film of a memory alloy that is shape set to a larger diameter than the radially expanded diameter of the stent body 152 within a body passageway. The resulting outward radial force exerted by the tubular member 154 against the stent body helps secure the tubular member and stent body. The tubular member outward force may supplement the outward force exerted by the stent body. As shown in Fig. 3, the tubular member includes, along the radial dimension, only a single layer. In other embodiments, tubular member 154 itself, or endoprosthesis 150 as a whole, includes multiple tubular member layers, e.g., multiple deposited metallic film layers. For example, a second tubular member can be disposed external of stent body 152. In embodiments, the tubular member is a thin film of super-elastic alloy and is not shape set.

Referring to Fig. 4, an endoprosthesis 200 includes a tubular member 254 sandwiched between an internal stent body 252 and an external stent body 253. Each stent body 252, 253 alone may exert less outward radial force than required to maintain a position of the deployed endoprosthesis within a body passageway. Hence, each stent body 252, 253 alone may be more radially compliant than a single stent body that provides sufficient radial force to secure an endoprosthesis. When loading the endoprosthesis 200 into a deployment device, the compliant stent bodies tolerate radial compaction without damage. When deployed, however, stent bodies 252, 253 cooperate to exert sufficient outward radial force to maintain the endoprosthesis in position within a body lumen. Either of stent bodies 252, 253 may exert a greater outward radial force than the other. In embodiments, internal stent body 252 exerts a greater radial outward force, which helps secure internal stent body 252 and tubular member 254 with respect to external stent body 253. hi embodiments, a radial thickness of each stent body 252, 253 is about 60 μm or less, about 50 μm or less, about 30 μm or less, e.g., about 25 μm or less. The total radial thickness of stent bodies 252, 253 may be about 120 μm or less, about 100 μm or less, about 60 μm or less, e.g., about 50 μm or less. One of the stent bodies 252, 253 may make up at least about 50%, at least about 75%, e.g., at least about 85% of the total radial thickness. In some embodiments, stent bodies 252, 253 and tubular member 254 are secured with respect to one another by filaments 101, which pass through fenestrations 265 of the tubular member and pass around and/or are secured to either or both of stent bodies 252,

253. hi embodiments, a given filament secures the tubular member with respect to one but not both stent bodies 252, 253. Endoprosthesis 200 can be configured so that stent bodies 252, 253 have relative freedom of movement with respect to one another and/or with respect to tubular member

254. The freedom of movement may be provided along a given dimension, e.g., a radial, a circumferential, a longitudinal dimension, or combination thereof. For example, filaments 101 may have a length sufficient to provide some freedom of movement. Filaments that pass around longitudinal members 258 can allow longitudinal movement whereas filaments that pass around portions of circumferential bands 257 can allow circumferential movement, hi some embodiments, stent bodies 252, 253 have essentially no freedom of movement along one or more dimensions, e.g., along one or all of the radial, circumferential, and longitudinal dimensions. Securing techniques alternative to or supplemental to filaments can be used.

Referring to Fig. 5, an endoprosthesis 300 includes a tubular member 354 sandwiched between an internal stent body and an external stent body. One or both of the stent bodies of endoprosthesis 300 can be secured to the other via radially extending projections. As seen in Fig. 5, the external stent body includes projections 353, each extending through a fenestration 365 of tubular member 354 and engaging a portion of the internal stent body, e.g., an aperture 355. Apertures may or may not be closed and can be formed within a longitudinal member 359 or circumferential band of the stent body. The apertures are positioned to receive the projections when the two stent bodies mate. An end 357 of each projection 353 can be flattened or otherwise broadened to prevent the projection from retracting through the aperture 355. Depending upon the relative shape and size of the apertures and projections, the apertures and projections can be configured to provide the stent bodies with radial, longitudinal and/or circumferential freedom of movement. Other examples of endoprostheses including a thin film as well as related systems and methods are described in U.S. provisional patent application no. 60/549,287, filed March 2, 2004, which application is incorporated herein by reference.

Methods and structures for securing a framework and one or more deposited thin film covers are described in U.S. patent application no. **/*** ***} attorney docket no. 10527-566001 , titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference.

An endoprosthesis may include a cover disposed externally to a framework as shown and/or internally of a framework. Endoprostheses having a cover including, e.g., a deposited thin film, disposed internally of a framework are described in U.S. patent application no. **/***,***, attorney docket no. 10527-567001, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference. An endoprosthesis may include features to enhance a flexibility of the endoprosthesis as described in U.S. patent application no. **/*** }***} attorney docket no. 10527-568001, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference.

An endoprosthesis may include a deposited thin film and a polymer as described in U.S. patent application no. **/*** ***t attorney docket no. 10527-596001, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference.

An endoprosthesis may include one or more filaments, e.g., wires, adapted to enhance mechanical properties of a deposited thin film as described in U.S. patent application no. **/***,***, attorney docket no. 10527-621001, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference.

Methods for loading an endoprosthesis into a delivery device and systems for delivering an endoprosthesis to a treatment site are described in U.S. patent application no. **/***,***, attorney docket no. 10527-569001, titled MEDICAL DE VICES INCLUDING METALLIC FILMS AND METHODS FOR LOADING AND DEPLOYING SAME, which application is incorporated herein by reference.

All publications, references, applications, and patents referred to herein are incorporated by reference in their entirety.

Other embodiments are within the claims.

Claims

CLAIMSWhat is claimed is:
1. An endoprosthesis for deployment within a body passage, comprising: a tubular framework; and a metallic film having a thickness of about 50 μm or less and disposed internally of the tubular framework.
2. The endoprosthesis of claim 1, wherein the endoprosthesis is self expandable.
3. The endoprosthesis of claim 1, wherein the tubular framework has an internal surface and wherein the metallic film is generally tubular in shape and has an outer surface that contacts the internal surface of the tubular framework.
4. The endoprosthesis of claim 1, wherein the metallic film comprises a super-elastic alloy of nickel and titanium.
5. The endoprosthesis of claim 1, wherein the endoprosthesis, when in a deployed state within a body passage, exerts an outward radial force against the body passage, essentially all of the outward radial force resulting from the tubular framework.
6. The endoprosthesis of claim 1, wherein the endoprosthesis has an internal surface, the internal surface substantially defined by an internal surface of the metallic film.
7. The endoprosthesis of claim 1, wherein the endoprosthesis comprises only one framework.
8. The endoprosthesis of claim 1, comprising a second tubular framework, the metallic film being sandwiched between the tubular framework and the second tubular framework.
9. The endoprosthesis of claim 8, wherein the endoprosthesis is self expanding.
10. The endoprosthesis of claim 8, wherein neither the tubular framework nor the second tubular framework, by itself, exerts a radial force sufficient to secure the endoprosthesis within a body passage.
11. The endoprosthesis of claim 10, wherein, when in a deployed state, the tubular framework and the second tubular framework each exerts a radial force, the radial force of the second tubular framework being greater than the radial force of the tubular framework.
12. The endoprosthesis of claim 8, wherein the metallic film comprises a super-elastic alloy comprising titanium and nickel, the super-elastic alloy not being shape set.
13. The endoprosthesis of claim 8, wherein a total radial thickness of the tubular framework and the second tubular framework is about 75 microns or less.
14. The endoprosthesis of claim 8, wherein the tubular framework and the second tubular framework have at least some relative freedom of movement along at least one of the radial, circumferential, and longitudinal dimensions..
15. The endoprosthesis of claim 1 , wherein substantially all of the metallic film is a single layer.
16. The endoprosthesis of claim 15, wherein the entire metallic film is a single layer.
17. A self-expanding endoprosthesis for deployment within a body passage, comprising: a first tubular framework; a tubular member disposed around the first tubular framework; and a second tubular framework disposed around the tubular member.
18. The self-expanding endoprosthesis of claim 17, wherein neither of the first and second tubular frameworks alone exerts sufficient outward radial force to self-expand the endoprosthesis within a body passage but the first and second tubular frameworks together exert sufficient outward radial force to self-expand the endoprosthesis.
19. The self-expanding endoprosthesis of claim 17, wherein the tubular member is a deposited metallic film comprising titanium and nickel and having a thickness of about 50 μm or less.
20. A delivery device for deploying an endoprosthesis within a body passage, comprising: an elongate inner member; a self-expanding endoprosthesis disposed about a distal portion of the inner member, the endoprosthesis comprising a tubular framework disposed about a deposited metallic film; and an outer sheath surrounding the elongate inner member and the self-expanding endoprosthesis, wherein the tubular framework prevents substantial frictional contact between the tubular member and the outer sheath.
PCT/US2005/006993 2004-03-02 2005-03-02 Medical devices including metallic films and methods for making same WO2006071243A1 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
US11025866 US8998973B2 (en) 2004-03-02 2004-12-29 Medical devices including metallic films
US11/025,660 2004-12-29
US11025660 US20060142838A1 (en) 2004-12-29 2004-12-29 Medical devices including metallic films and methods for loading and deploying same
US11025860 US8591568B2 (en) 2004-03-02 2004-12-29 Medical devices including metallic films and methods for making same
US11025158 US8632580B2 (en) 2004-12-29 2004-12-29 Flexible medical devices including metallic films
US11/025,464 2004-12-29
US11025867 US20050197687A1 (en) 2004-03-02 2004-12-29 Medical devices including metallic films and methods for making same
US11/025,158 2004-12-29
US11/025,867 2004-12-29
US11025684 US7901447B2 (en) 2004-12-29 2004-12-29 Medical devices including a metallic film and at least one filament
US11/025,860 2004-12-29
US11025464 US8992592B2 (en) 2004-12-29 2004-12-29 Medical devices including metallic films
US11/025,866 2004-12-29
US11/025,684 2004-12-29
PCT/US2005/006993 WO2006071243A1 (en) 2004-12-29 2005-03-02 Medical devices including metallic films and methods for making same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2005/006993 WO2006071243A1 (en) 2004-12-29 2005-03-02 Medical devices including metallic films and methods for making same

Publications (1)

Publication Number Publication Date
WO2006071243A1 true true WO2006071243A1 (en) 2006-07-06

Family

ID=39789826

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/006993 WO2006071243A1 (en) 2004-03-02 2005-03-02 Medical devices including metallic films and methods for making same

Country Status (1)

Country Link
WO (1) WO2006071243A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8864815B2 (en) 2004-12-29 2014-10-21 Boston Scientific Scimed, Inc. Medical devices including metallic film and at least one filament
US8992592B2 (en) 2004-12-29 2015-03-31 Boston Scientific Scimed, Inc. Medical devices including metallic films
US8998973B2 (en) 2004-03-02 2015-04-07 Boston Scientific Scimed, Inc. Medical devices including metallic films
US9023094B2 (en) 2007-06-25 2015-05-05 Microvention, Inc. Self-expanding prosthesis
CN104939947A (en) * 2014-03-26 2015-09-30 上海市第六人民医院 Brain covered stent with endothelial progenitor cell capture function

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5667523A (en) * 1995-04-28 1997-09-16 Impra, Inc. Dual supported intraluminal graft
US20010032013A1 (en) * 1999-11-19 2001-10-18 Denes Marton Self-supporting laminated films, structural materials and medical devices manufactured therefrom and method of making same
US20020019662A1 (en) * 2000-06-05 2002-02-14 Brauckman Richard A. Device for delivering a radioactive and/or drug dosage alone or in connection with a vascular stent
WO2003013337A2 (en) * 2001-08-07 2003-02-20 Advanced Bio Prosthetic Surfaces, Ltd. Medical grafts having plurality of microperforations
US20030127318A1 (en) * 2000-01-24 2003-07-10 Johnson A. David Method for sputtering TiNi shape-memory alloys
WO2004002370A1 (en) * 2002-06-28 2004-01-08 Cook Incorporated Thoracic aortic aneurysm stent graft

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5667523A (en) * 1995-04-28 1997-09-16 Impra, Inc. Dual supported intraluminal graft
US20010032013A1 (en) * 1999-11-19 2001-10-18 Denes Marton Self-supporting laminated films, structural materials and medical devices manufactured therefrom and method of making same
US20030127318A1 (en) * 2000-01-24 2003-07-10 Johnson A. David Method for sputtering TiNi shape-memory alloys
US20020019662A1 (en) * 2000-06-05 2002-02-14 Brauckman Richard A. Device for delivering a radioactive and/or drug dosage alone or in connection with a vascular stent
WO2003013337A2 (en) * 2001-08-07 2003-02-20 Advanced Bio Prosthetic Surfaces, Ltd. Medical grafts having plurality of microperforations
WO2004002370A1 (en) * 2002-06-28 2004-01-08 Cook Incorporated Thoracic aortic aneurysm stent graft

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8998973B2 (en) 2004-03-02 2015-04-07 Boston Scientific Scimed, Inc. Medical devices including metallic films
US8864815B2 (en) 2004-12-29 2014-10-21 Boston Scientific Scimed, Inc. Medical devices including metallic film and at least one filament
US8992592B2 (en) 2004-12-29 2015-03-31 Boston Scientific Scimed, Inc. Medical devices including metallic films
US9023094B2 (en) 2007-06-25 2015-05-05 Microvention, Inc. Self-expanding prosthesis
CN104939947A (en) * 2014-03-26 2015-09-30 上海市第六人民医院 Brain covered stent with endothelial progenitor cell capture function

Similar Documents

Publication Publication Date Title
US6458152B1 (en) Coiled sheet graft for single and bifurcated lumens and methods of making and use
US7713297B2 (en) Drug-releasing stent with ceramic-containing layer
US7125419B2 (en) Noncylindrical stent deployment for treating vascular bifurcations
US7691461B1 (en) Hybrid stent and method of making
US6015431A (en) Endolumenal stent-graft with leak-resistant seal
US6613077B2 (en) Stent with controlled expansion
US7004962B2 (en) Neuroaneurysm occlusion and delivery device and method of using same
US6251135B1 (en) Radiopaque marker system and method of use
EP0701800B1 (en) Vascular endoprosthesis with hook
US20030120332A1 (en) Stent graft with improved graft adhesion
US5749921A (en) Apparatus and methods for compression of endoluminal prostheses
US20030139796A1 (en) Endoprosthesis deployment system for treating vascular bifurcations
US6224609B1 (en) Bifurcated prosthetic graft
US20050165470A1 (en) Medical devices
US20070168019A1 (en) Intravascular deliverable stent for reinforcement of vascular abnormalities
US20020077693A1 (en) Covered, coiled drug delivery stent and method
US8535368B2 (en) Apparatus for loading and delivering a stent
US20050246010A1 (en) Delivery catheter that controls foreshortening of ribbon-type prostheses and methods of making and use
US7309349B2 (en) Friction reducing lubricant for stent loading and stent delivery systems
EP1362564A1 (en) Intravascular stent device
US20060276887A1 (en) Integrated stent repositioning and retrieval loop
US6258115B1 (en) Bifurcated stent and distal protection system
US20040267281A1 (en) Delivery system for self-expandable diverter
US7344560B2 (en) Medical devices and methods of making the same
US5683451A (en) Apparatus and methods for deployment release of intraluminal prostheses

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05724520

Country of ref document: EP

Kind code of ref document: A1